Clinical Trial Update: Tau Screening Study in Subjects With Early Symptomatic AD [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for tau screening in early symptomatic Alzheimer's disease completed, with results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Snippet

Sponsor: Avid Radiopharmaceuticals | Conditions: Alzheimer Disease | Phase 2 | Status: COMPLETED | Results posted: 2020-08-24